# Early Detection of Concealed Cardiac Amyloidosis Using AI-ECG and CT-Derived Extracellular Volume in Patients With Atrial Fibrillation

> **NCT07567508** · NA · NOT_YET_RECRUITING · sponsor: **Samsung Medical Center** · enrollment: 500 (estimated)

## Conditions studied

- Atrial Fibrillation (AF)
- Cardiac Amyloidosis

## Interventions

- **DIAGNOSTIC_TEST:** AI-ECG analysis
- **DIAGNOSTIC_TEST:** CT-ECV analysis
- **OTHER:** Atrial fibrillation treatment

## Key facts

- **NCT ID:** NCT07567508
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2029-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07567508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07567508, "Early Detection of Concealed Cardiac Amyloidosis Using AI-ECG and CT-Derived Extracellular Volume in Patients With Atrial Fibrillation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07567508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*